首页 国际期刊 医学期刊 期刊详情(非官网)
400-808-1701

Clinical Genitourinary Cancer

Clinical Genitourinary Cancer杂志,由Elsevier出版,于2005年创刊,Quarterly,出版语言English,ISSN:1558-7673,E-ISSN:1938-0682。

投稿咨询
Clinical Genitourinary Cancer
Clinical Genitourinary Cancer
Clinical Genitourinary Cancer
SCI SCIE

杂志介绍

JCR分区
Q2
中科院分区
3区
影响因子
2.4
CiteScore
4
期刊收录
SCI、SCIE

Clinical Genitourinary Cancer(中文译名:《临床泌尿生殖系癌》),ISSN:1558-7673,EISSN:1938-0682,是Elsevier出版的国际性学术期刊,创刊于2005年,以Quarterly形式稳定发行,2026年总发文量约172篇。该刊采用非OA开放访问,学科归属为医学 - 泌尿学与肾脏学。该刊是医学、肿瘤学领域的国际权威刊物,已被SCI(科学引文索引)、SCIE(科学引文索引扩展版)等国际主流学术数据库收录。2026年期刊影响因子达2.4,2025年期刊CiteScore为4,2025年期刊自引率约4.2%,在中科院期刊分区体系中位列医学大类3区,在所属学科领域具备高学术影响力与国际认可度。Clinical Genitourinary Cancer长期聚焦医学、肿瘤学及相关产业的技术应用前沿,平均审稿周期较慢,6-12周,审稿流程高效稳定。在稿件录用评判中,该刊将创新性与前沿性作为核心遴选标准,重点收录能够对医学、肿瘤学领域的落地与发展产生实质性推动价值的研究成果。

从全球发文格局来看,USAItaly、Canada、GERMANY (FED REP GER)、France、Japan、Austria等为核心发文国家与地区;UNIVERSITY OF TEXAS SYSTEMHARVARD UNIVERSITY、MEDICAL UNIVERSITY OF VIENNA、DANA-FARBER CANCER INSTITUTE、UNIVERSITY OF HAMBURG、UNIVERSITY OF MONTREAL、UNIVERSITY OF CALIFORNIA SYSTEM等高校与科研机构是期刊的主要发文单位。

期刊评价

名词解释:

影响因子(Impact Factor, IF):指该期刊前两年发表的文章,在第三年的平均被引用次数。它反映了期刊的近期平均影响力和热度。

中科院分区:中科院分区表是国内主流的学术期刊分级评价工具,核心意义是建立跨学科可比的统一评价标尺,为职称评审、学位授予、科研立项等科研管理工作提供标准化量化依据,同时帮助科研人员筛选优质期刊、规避学术风险,适配国内本土化的科研评价需求。

期刊分区表

《新锐期刊分区表》(2026年3月发布)

大类学科 小类学科 Top期刊 综述期刊
医学
3区
ONCOLOGY 肿瘤学 UROLOGY & NEPHROLOGY 泌尿学与肾脏学
3区 3区

期刊分区表(2025年3月升级版)

大类学科 小类学科 Top期刊 综述期刊
医学
3区
UROLOGY & NEPHROLOGY 泌尿学与肾脏学 ONCOLOGY 肿瘤学
3区 4区

期刊分区表(2023年12月升级版)

大类学科 小类学科 Top期刊 综述期刊
医学
3区
ONCOLOGY 肿瘤学 UROLOGY & NEPHROLOGY 泌尿学与肾脏学
3区 3区

JCR分区

2025-2026年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:ONCOLOGY SCIE Q3 214 / 333

35.9

学科:UROLOGY & NEPHROLOGY SCIE Q2 57 / 134

57.8

学科:ONCOLOGY SCIE Q2 133 / 333

60.21

学科:UROLOGY & NEPHROLOGY SCIE Q2 53 / 134

60.82

2024-2025年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:ONCOLOGY SCIE Q3 171 / 328

48

学科:UROLOGY & NEPHROLOGY SCIE Q2 39 / 133

71.1

学科:ONCOLOGY SCIE Q2 103 / 328

68.75

学科:UROLOGY & NEPHROLOGY SCIE Q2 39 / 133

71.05


中国学者近期发文

1
Histological Evaluation of Tertiary Lymphoid Structures Predicts Prognosis in Upper Tract Urothelial Carcinoma: A Cox-Based Nomogram Analysi

Author:Xu, Liqing; Ying, Honggang; Yang, Jieping; Huang, Yixuan; Huang, Yiwei; Li, Xinfei; Li, Zhihua; Tang, Qi; Yang, Kunlin; Li, Xuesong

Journal: CLINICAL GENITOURINARY CANCER. 2026; Vol. 24, Issue 4, pp. -. DOI: 10.1016/j.clgc.2026.102542

2
Renal Pelvic Urothelial Carcinoma With Venous Tumor Thrombus: Prognosis and Reconsideration of TNM Stagin

Author:Xie, Ruiyang; Lu, Min; Wu, Jie; Zhang, Zhanyi; Du, Zhiming; Liu, Lei; Wang, Guoliang; Tian, Xiaojun; Zhao, Lei; Zhang, Hongxian; Ma, Lulin; Yan, Ye; Zhang, Shudong

Journal: CLINICAL GENITOURINARY CANCER. 2026; Vol. 24, Issue 3, pp. -. DOI: 10.1016/j.clgc.2026.102503

3
TNM Stage-Stratified Comparison Between Urachal and Nonurachal Adenocarcinomas of the Bladder: A Single-Center Retrospective Cohort Stud

Author:Zhu, Jianhang; Ma, Xiaocheng; Xie, Fei; Wang, Yonghua

Journal: CLINICAL GENITOURINARY CANCER. 2026; Vol. 24, Issue 3, pp. -. DOI: 10.1016/j.clgc.2026.102509

4
Association of PD-L1 and PD-1 Expression With Clinicopathological Characteristics and Prognosis in Upper Tract Urothelial Carcinom

Author:Li, Peng; Zhang, Xiaolei; Yang, Xiao; Li, Hai; Song, Guoxin; Lu, Qiang; Li, Pengchao

Journal: CLINICAL GENITOURINARY CANCER. 2026; Vol. 24, Issue 2, pp. -. DOI: 10.1016/j.clgc.2025.102497

5
Comparison of the Oncologic Outcomes of Cryoablation, Laser Ablation, and Hyperthermia for Localized Prostate Cancer: A Population-Based Cohort Study Using the SEER Databas

Author:Guo, Run-Qi; Sun, Jie; Bie, Zhi-Xin; Li, Yuan-Ming

Journal: CLINICAL GENITOURINARY CANCER. 2026; Vol. 24, Issue 1, pp. -. DOI: 10.1016/j.clgc.2025.102490

6
Impact of Muscle Depletion on Prognosis in Patients Undergoing Radical Cystectom

Author:Pang, Xiangyu; Jiang, Lei; Wang, Haiyun; Luo, Lei; Liu, Tongpeng; Sun, Lijiang; Zhang, Guiming

Journal: CLINICAL GENITOURINARY CANCER. 2025; Vol. 23, Issue 4, pp. -. DOI: 10.1016/j.clgc.2025.102373

7
Modifiable Cardiovascular Risk Factors Amongst Men With and Without Prostate Cancer in a Large, Prospective Registr

Author:Janopaul-Naylor, James; Yadalam, Adithya K.; Chan, Jeffrey Shi Kai; Dee, Edward Christopher; V. Sun, Yan; Cantu, Stephanie M.; Mandawat, Anant; Patel, Sagar A

Journal: CLINICAL GENITOURINARY CANCER. 2025; Vol. 23, Issue 3, pp. -. DOI: 10.1016/j.clgc.2025.102340

8
Geographic Distribution of Racial Differences in Renal Cell Carcinoma Mortalit

Author:Liu, Xiaoxian; Shi, Chengqian; Han, Bin; Yang, Jie

Journal: CLINICAL GENITOURINARY CANCER. 2025; Vol. 23, Issue 3, pp. -. DOI: 10.1016/j.clgc.2025.102324

9
Impact of TP53 Alterations on Clinical Outcomes in Penile Squamous Cell Carcinom

Author:Li, Yajian; Tian, Ziru; Si, Zhannan; Wang, Yifan; Song, Gang

Journal: CLINICAL GENITOURINARY CANCER. 2025; Vol. 23, Issue 3, pp. -. DOI: 10.1016/j.clgc.2025.102323

10
Causal Associations Between the Presence of Prostate Cancer or Testosterone Levels and Bladder Cancer Risk: A Mendelian Randomization Stud

Author:Ren, Wenbiao; Zhu, Yewen

Journal: CLINICAL GENITOURINARY CANCER. 2025; Vol. 23, Issue 3, pp. -. DOI: 10.1016/j.clgc.2025.102334


在线咨询

Clinical Genitourinary Cancer

国际简称:CLIN GENITOURIN CANC参考译名:临床泌尿生殖系癌

年发文量:172 CiteScore:4 是否预警:否 Gold OA文章占比:19.53% 研究类文章占比:90.12%

杂志社联系方式:CIG MEDIA GROUP, LP, 3500 MAPLE AVENUE, STE 750, DALLAS, USA, TX, 75219-3931

Clinical Genitourinary Cancer